Plants as Sources of Natural and Recombinant Anti-Cancer Agents

A special issue of Plants (ISSN 2223-7747). This special issue belongs to the section "Phytochemistry".

Deadline for manuscript submissions: 31 January 2027 | Viewed by 120

Special Issue Editors


E-Mail Website
Guest Editor
Unit for Environmental Sciences and Management (UESM), Faculty of Natural and Agricultural Sciences, North-West University, Potchefstroom 2520, South Africa
Interests: medicinal plants; ethnobotany; phytochemistry; antioxidants; plant nutraceuticals
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Biochemistry Programmme, College of Agriculture, Engineering and Science, Bowen University, Iwo 232102, Osun State, Nigeria
Interests: phytomedicine; metabolic diseases

E-Mail Website
Guest Editor Assistant
Department of Clinical & Social Pharmaceutical Sciences, College of Pharmacy, Touro University, 1310 Club Dr., Vallejo, CA 94592, USA
Interests: research methods; process evaluation; acute and chronic disease management; pharmacology

Special Issue Information

Dear Colleagues,

Plants have served as humanity's primary source of therapeutic agents throughout history, and they continue to underpin a significant proportion of the modern oncology pharmacopoeia. From ethnobotanical traditions to cutting-edge molecular farming and synthetic biology, the plant kingdom offers an extraordinary and largely unexplored reservoir of bioactive compounds and recombinant biologics with anti-cancer potential.

This Special Issue invites original research articles, comprehensive reviews, systematic reviews, and communications that advance our understanding of plant-derived and recombinant anti-cancer agents spanning the full discovery-to-translation pipeline: from ethnobotanical knowledge and phytochemical characterisation, through mechanistic oncology studies and biotechnological production, to nano-formulation strategies and early clinical evidence.

Scope and topics of interest include:

  • Ethnobotany and traditional medicine;
  • Natural plant-derived compounds;
  • Recombinant anti-cancer agents from plant systems;
  • Mechanisms of anti-cancer action;
  • Biosynthetic pathways and metabolic engineering;
  • Nano-formulation and drug delivery;
  • Synergistic and combination strategies;
  • Preclinical and translational studies.

Dr. Tomi Lois Adetunji
Prof. Dr. Ademola Olabode Ayeleso
Guest Editors

Dr. Taiwo Opeyemi Aremu
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • medicinal plants
  • plant secondary metabolites
  • cytotoxicity
  • bioavailability
  • nanoparticle delivery
  • anti-cancer activity
  • ethnopharmacology
  • bioprospecting
  • pharmacokinetics
  • combination therapy
  • cancer immunotherapy
  • flavonoids
  • natural product drug discovery
  • autophagy
  • plant-made pharmaceuticals
  • phytotherapy
  • toxicity-profiling
  • drug-resistance
  • structure–activity relationship

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop